-
SANOFI-AVENTIS U.S. LLC et al v. SANDOZ, INC. DC CAFC
- 3:07-cv-02762
- D.N.J.
- Judge: Joel A. Pisano
+2
- Filed: 06/14/2007
- Closed: 09/16/2011
- Latest Docket Entry: 10/25/2012
- PACER
3
Plaintiffs
28
Defendants
1
Accused
Product
2
Patents-in-Suit
1,556
Days in
Litigation
-
SANOFI-AVENTIS U.S. LLC et al v. SANDOZ, INC. DC CAFC
- 3:07-cv-02762
- D.N.J.
- Judge: Joel A. Pisano
+2
- Filed: 06/14/2007
- Closed: 09/16/2011
- Latest Docket Entry: 10/25/2012
- PACER
Market Sector
Biotech and Pharma
Court
Referred Judges
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Abraxis Bioscience Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Actavis Group
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Actavis Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Actavis Totowa LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
APP Pharmaceuticals Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Barr Laboratories Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Dabur Pharma Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic injectable oxaliplatin formulations | US 5,338,874 A | All Asserted Claims |
Infringement
Entry 605
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Fresenius Kabi Oncology PLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Fresenius Kabi Pharma Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic injectable oxaliplatin formulationsGeneric oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
Infringement
Entry 411Entry 605 |
Hospira Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Mayne Pharma Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Mayne Pharma (USA) Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Mustafa Nevzat Ilac Sanayii A.S.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Par Pharmaceutical, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Pharmachemie BV
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Pliva-Lachema As
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Sandoz Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Teva Parenteral Medicines
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
Teva Pharmaceuticals USA, Inc.
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
WC Heraeus GmbH
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic oxaliplatin solution for injection 50 mg vial, 100 mg vial | US 5,338,874 A | All Asserted Claims |
No infringement
Entry 411
|
